Intrinsic Value
Celyad Oncology SA (CYAD.BR)
0.3395 €
+0.01 (+4.14%)
| Enterprise Value | -129.12 |
|---|---|
| Net Debt | 10.69 |
| Equity Value | -139.80 |
| Shares Outstanding | 25.72 |
| Equity Value Per Share | -5.44 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt